Dipti Kanabar

481 total citations
17 papers, 398 citations indexed

About

Dipti Kanabar is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Dipti Kanabar has authored 17 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Dipti Kanabar's work include Ubiquitin and proteasome pathways (7 papers), Autophagy in Disease and Therapy (5 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Dipti Kanabar is often cited by papers focused on Ubiquitin and proteasome pathways (7 papers), Autophagy in Disease and Therapy (5 papers) and Inhalation and Respiratory Drug Delivery (3 papers). Dipti Kanabar collaborates with scholars based in United States, Egypt and Taiwan. Dipti Kanabar's co-authors include Aaron Muth, Vivek Gupta, Snehal K. Shukla, Vineela Parvathaneni, Nishant S. Kulkarni, Bhuvaneshwar Vaidya, Seyoum Ayehunie, Samir Mitragotri, Apoorva Sarode and Jerome Garcia and has published in prestigious journals such as Journal of Medicinal Chemistry, Carbohydrate Polymers and Pharmaceutical Research.

In The Last Decade

Dipti Kanabar

15 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dipti Kanabar United States 9 137 136 124 114 82 17 398
Noratiqah Mohtar Malaysia 10 133 1.0× 157 1.2× 211 1.7× 97 0.9× 101 1.2× 18 568
Deepa Patel India 9 102 0.7× 150 1.1× 271 2.2× 71 0.6× 67 0.8× 18 513
Feifei Yang China 11 88 0.6× 120 0.9× 111 0.9× 78 0.7× 57 0.7× 16 360
Geetanjali Chimote India 10 89 0.6× 163 1.2× 85 0.7× 111 1.0× 59 0.7× 15 417
Raghuvir H. Gaonkar India 11 135 1.0× 203 1.5× 79 0.6× 51 0.4× 70 0.9× 25 530
Nagarjun Rangaraj India 14 141 1.0× 152 1.1× 245 2.0× 54 0.5× 78 1.0× 18 599
Dasharath Chaudhari India 16 230 1.7× 230 1.7× 132 1.1× 64 0.6× 143 1.7× 28 577
Pei Kan Taiwan 12 175 1.3× 121 0.9× 115 0.9× 55 0.5× 84 1.0× 17 438
Samuel V. Mussi Brazil 12 195 1.4× 192 1.4× 123 1.0× 34 0.3× 104 1.3× 14 456
Rinku Baishya India 12 102 0.7× 164 1.2× 50 0.4× 42 0.4× 53 0.6× 31 412

Countries citing papers authored by Dipti Kanabar

Since Specialization
Citations

This map shows the geographic impact of Dipti Kanabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipti Kanabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipti Kanabar more than expected).

Fields of papers citing papers by Dipti Kanabar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dipti Kanabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipti Kanabar. The network helps show where Dipti Kanabar may publish in the future.

Co-authorship network of co-authors of Dipti Kanabar

This figure shows the co-authorship network connecting the top 25 collaborators of Dipti Kanabar. A scholar is included among the top collaborators of Dipti Kanabar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dipti Kanabar. Dipti Kanabar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Kanabar, Dipti, et al.. (2024). Synthesis and Evaluation of 2,5-Substituted Pyrimidines as Small-Molecule Gankyrin Binders. Future Medicinal Chemistry. 16(3). 239–251.
3.
Shukla, Snehal K., Dipti Kanabar, Seyoum Ayehunie, et al.. (2024). Exploring the enhanced stability and therapeutic efficacy of Sorafenib-Cyclodextrin inclusion complex. Journal of Molecular Liquids. 401. 124701–124701. 1 indexed citations
4.
Kanabar, Dipti, et al.. (2023). Poly vinyl pyrrolidone (PVP) based inhaled delivery carriers for olaparib for non-small cell lung cancer (NSCLC) treatment. Journal of Drug Delivery Science and Technology. 87. 104767–104767. 7 indexed citations
5.
Gnanamony, Manu, Maria Thomas, Peter J. Hanley, et al.. (2022). Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer. Cancers. 14(13). 3068–3068. 1 indexed citations
6.
Kanabar, Dipti, Xuechun Wang, Snehal K. Shukla, et al.. (2022). Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer. Journal of Medicinal Chemistry. 65(13). 8975–8997. 6 indexed citations
7.
Kanabar, Dipti, et al.. (2021). Identification of novel gankyrin binding scaffolds by high throughput virtual screening. Bioorganic & Medicinal Chemistry Letters. 43. 128043–128043. 2 indexed citations
8.
Shukla, Snehal K., Apoorva Sarode, Dipti Kanabar, et al.. (2021). Bioinspired particle engineering for non-invasive inhaled drug delivery to the lungs. Materials Science and Engineering C. 128. 112324–112324. 17 indexed citations
9.
Kanabar, Dipti, et al.. (2020). Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 30(17). 127372–127372. 9 indexed citations
10.
Parvathaneni, Vineela, Rasha S. Elbatanony, Snehal K. Shukla, et al.. (2020). Bypassing P-glycoprotein mediated efflux of afatinib by cyclodextrin complexation – Evaluation of intestinal absorption and anti-cancer activity. Journal of Molecular Liquids. 327. 114866–114866. 16 indexed citations
11.
Shukla, Snehal K., Nishant S. Kulkarni, Dipti Kanabar, et al.. (2020). Sorafenib Loaded Inhalable Polymeric Nanocarriers against Non-Small Cell Lung Cancer. Pharmaceutical Research. 37(3). 67–67. 57 indexed citations
12.
Wang, Xuechun, Vineela Parvathaneni, Snehal K. Shukla, et al.. (2020). Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol—Applications in Non-small Cell Lung Cancer Treatment. AAPS PharmSciTech. 21(5). 183–183. 37 indexed citations
13.
Kanabar, Dipti & Aaron Muth. (2020). Exploring gankyrin’s Role in Cancer Development and Its Potential As a Therapeutic Target. Future Medicinal Chemistry. 12(18). 1603–1606. 2 indexed citations
14.
Shukla, Snehal K., Amanda Chan, Vineela Parvathaneni, et al.. (2020). Enhanced solubility, stability, permeation and anti-cancer efficacy of Celastrol-β-cyclodextrin inclusion complex. Journal of Molecular Liquids. 318. 113936–113936. 51 indexed citations
15.
Kanabar, Dipti, et al.. (2019). Structural modification of the aryl sulfonate ester of cjoc42 for enhanced gankyrin binding and anti-cancer activity. Bioorganic & Medicinal Chemistry Letters. 30(4). 126889–126889. 21 indexed citations
16.
Vaidya, Bhuvaneshwar, Vineela Parvathaneni, Nishant S. Kulkarni, et al.. (2018). Cyclodextrin modified erlotinib loaded PLGA nanoparticles for improved therapeutic efficacy against non-small cell lung cancer. International Journal of Biological Macromolecules. 122. 338–347. 106 indexed citations
17.
Vaidya, Bhuvaneshwar, Snehal K. Shukla, Srikanth Kolluru, et al.. (2018). Nintedanib-cyclodextrin complex to improve bio-activity and intestinal permeability. Carbohydrate Polymers. 204. 68–77. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026